Drug Type Small molecule drug |
Synonyms |
Target- |
Action inhibitors |
Mechanism Virus internalization inhibitors, Virus replication inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemorrhagic Fever, Ebola | Phase 2 | - | - | |
Marburg Virus Disease | Preclinical | United States | 24 Apr 2020 | |
Lassa Fever | Preclinical | United States | 21 Apr 2020 | |
Hantavirus Infections | Preclinical | United States | 17 Apr 2020 | |
COVID-19 | Preclinical | United States | 11 Apr 2020 | |
Respiratory Syncytial Virus Infections | Preclinical | United States | 28 Aug 2016 |